Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Updated on: July 01,2024 0

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Updated on:July 01,2024 0

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on: July 19,2024 0

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on:July 19,2024 0

Two-organ chip developed to answer fatty liver questions

by Kyoto UniversityThe interaction between the small intestine and the liver of patients with non-alcoholic fatty liver disease (NAFLD) has been reproduced on a small chip. Credit: Mindy Takamiya

Updated on: May 29,2024 6

Two-organ chip developed to answer fatty liver questions

by Kyoto UniversityThe interaction between the small intestine and the liver of patients with non-alcoholic fatty liver disease (NAFLD) has been reproduced on a small chip. Credit: Mindy Takamiya

Updated on:May 29,2024 6

Enhancing Anti-Tumor Immune Response in Small Cell Lung Cancer Through Combined Radiotherapy and CD47 Blockade: Mechanisms and Therapeutic Potential

Updated on: July 20,2024 0

Enhancing Anti-Tumor Immune Response in Small Cell Lung Cancer Through Combined Radiotherapy and CD47 Blockade: Mechanisms and Therapeutic Potential

Updated on:July 20,2024 0

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on: September 02,2024 0

Novel pathway could lead to potential treatment for metabolic liver disease

by Hayley Mignacca,University of Massachusetts Medical SchoolLyz-IFNγR2−/−mice are rescued from fatty liver progression to MASH. Credit:Nature Communications(2024). DOI: 10.103

Updated on:September 02,2024 0

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on: June 01,2024 6

Popular diabetes drug may also reduce the risk of severe liver disease

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainOzempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes

Updated on:June 01,2024 6

Everything to Know About Alcoholic Liver Disease

Everything to Know About Alcoholic Liver DiseaseByCory MartinUpdated on December 19, 2023Medically reviewed byJay N. Yepuri, MDAlcoholic liver disease (ALD) is caused by excess

Updated on: July 01,2024 0

Everything to Know About Alcoholic Liver Disease

Everything to Know About Alcoholic Liver DiseaseByCory MartinUpdated on December 19, 2023Medically reviewed byJay N. Yepuri, MDAlcoholic liver disease (ALD) is caused by excess

Updated on:July 01,2024 0

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Updated on: June 06,2024 3

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Updated on:June 06,2024 3

How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your LiverSupport liver health with these fruits, vegetables, and beveragesByLauren Panoff, MPH, RDPublished on August 08, 2023Medically reviewed by&nbsp

Updated on: July 01,2024 0

How to Choose Good Foods for Your Liver

How to Choose Good Foods for Your LiverSupport liver health with these fruits, vegetables, and beveragesByLauren Panoff, MPH, RDPublished on August 08, 2023Medically reviewed by&nbsp

Updated on:July 01,2024 0

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Updated on: March 20,2024 10

Mechanism for silencing gene expression targets the culprit behind a deadly liver cancer

by Sanford M. Simon,Rockefeller UniversityASGR1 in FLC. (A) RNA expression analysis of ASGR1 across patient samples. (B) Immunofluorescence of ASGR1 in tumor-adjacent healthy liver, primary tumo

Updated on:March 20,2024 10

Study compares rivaroxaban, warfarin with apixaban for cirrhosis, atrial fibrillation

by Elana GotkineFor patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, accordi

Updated on: July 10,2024 0

Study compares rivaroxaban, warfarin with apixaban for cirrhosis, atrial fibrillation

by Elana GotkineFor patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, accordi

Updated on:July 10,2024 0

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on: June 06,2024 6

Liver function tests can ID occult disorders in systemic sclerosis

by Elana GotkineLiver function test (LFT) screening can identify occult hepatitis, cholestasis, and cholestatic hepatitis in patients with systemic sclerosis (SSc), according to a study published onli

Updated on:June 06,2024 6